Table 4.
Clinical outcomes.
| Outcome | N = 36 n (%) |
|---|---|
| Clinical responsea at end-of-treatment: | |
| Complete/partial | 21 (58.3) |
| Complete | 11 (30.6) |
| Partial | 10 (27.8) |
| Failure | 15 (41.7) |
| Overall responseb at end-of-treatment: | |
| Complete | 7 (19.4) |
| Partial | 6 (16.7) |
| Stable | 6 (16.7) |
| Progression | 17 (47.2) |
| Survival at day 42 | 29 (80.6) |
| Survival at day 84 | 25 (69.4) |
aClinical response is defined as the resolution or partial resolution of all attributable clinical symptoms and physical findings.
bOverall response was based on a composite of clinical, mycological, and radiological response as assessed by a data review committee or the treating physicians for patients in the named-patient program.